Dexcom | DXCM - 应收帐款人

金融业

USD 86.04

USD 6.46B

现金及等价物

USD 1.11B

USD 478.4M

USD 4.09B

USD 2.36B

USD 1.24B

USD 318.3M

USD 364.5M

10.3K

EPS每股收益

USD 0.7

股本和储备

USD 2.62B

USD 750.3M

债务利息支出

USD 3.1M

USD 19.5M

USD 1.3B

USD 34.4B

USD 249.1M

USD 990.1M

USD 318.3M

普通股股本

USD 377.4M

24.61

USD 269.5M

USD 1.31B

销售和管理费用

USD 358.7M

USD 726.4M

贸易债权人

USD 2.08B

应收帐款人

USD 1.27B

	应收帐款人	更改		日
Abbott	USD 11.22B		655M	2026-03
Align Technology	USD 1.15B		23.28M	2026-06
AtriCure	USD 79.98M		8.67M	2026-06
Baxter International	USD 1.86B		158M	2026-06
Becton, Dickinson and Co.	USD 2.36B		159M	2026-06
Boston Scientific	USD 3.03B		101M	2026-03
Cooper Companies	USD 788.9M		20.3M	2026-06
Dexcom	USD 1.27B		175.4M	2026-06
Edwards Lifesciences	USD 973M		60.9M	2026-03
Globus Medical	USD 739.28M		3.84M	2026-06
Inogen	USD 37.09M		4.11M	2024-06
Insulet	USD 588.7M		44M	2026-06
Integra LifeSciences	USD 267.19M		2.78M	2026-06
J&J	USD 19.05B		3.49B	2026-06
Medtronic	USD 6.36B		286M	2026-06
Merit Medical Systems	USD 250.9M		23.9M	2026-06
Roche Holding	CHF 13.34B		1.44B	2026-06
Solventum Corp	USD 1.69B		346M	2026-06
Stryker	USD 3.74B		172M	2026-06
Tandem Diabetes Care	USD 162.06M		21.39M	2026-06
Teleflex	USD 364.61M		917K	2026-06
West Pharmaceutical Services	USD 712M		26.4M	2026-06
Zimmer Biomet Holdings	USD 1.77B		40.9M	2026-06